Sanmina — global maker of complex electronic, optical and mechanical products — today announced it has achieved Medical Device Single Audit Program (MDSAP) certification at its facilities in Malaysia, Singapore and Sweden.
The MDSAP certification means the three manufacturing sites can be audited once by an accredited third party to satisfy regulations for medical device markets across Australia, Brazil, Canada, Japan and the U.S.
“Medical devices have become increasingly sophisticated and our customers expect us to provide the highest levels of quality and consistency during the production of these complex products,” said Anca Thompson, SVP and chief quality officer at Sanmina. “Achieving MDSAP certification further validates to our customers that we are producing safe and effective medical products that comply with all of the regulatory requirements across these regions.”
Sanmina designs and manufactures a broad range of blood and molecular diagnostics, medical imaging and patient monitoring equipment, as well as high-volume Class I, II and III medical devices.